Eton Pharmaceuticals, Inc. ( ETON) - Key Metrics
ETON Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.79 | $0.06 | -$0.82 | -$0.82 |
| 2025Q3 | $0.84 | -$0.07 | $0.45 | $0.44 |
| 2025Q2 | $0.70 | -$0.10 | $0.30 | $0.30 |
| 2025Q1 | $0.64 | -$0.06 | $0.08 | $0.08 |
ETON Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 76.71 |
| 2025Q3 | ? | -75.82 |
| 2025Q2 | ? | -37.06 |
| 2025Q1 | ? | -55.50 |
ETON Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.09% | ? |
| 2025Q4 | -2.55% | ? |
| 2025Q3 | 2.01% | ? |
| 2025Q2 | 2.08% | ? |
| 2025Q1 | 0.60% | ? |
ETON
Price: $43.20
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 36257
Market Capitalization: 1.0 billion